Chih-Ching Lin

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 3

Top Topics

Randomized Controlled Trial

Chronic Kidney Disease

Ejection Fraction

Top Venues

Clinical journal of the American Society of Nephrology : CJASN

National Yang-Ming University School of Medicine

National Yang-Ming University School of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Yang-Ming University School of Medicine Aug 01 2013

Taiwan

Professor

Taipei Veterans General Hospital

Taiwan

Attending physician :: Department of Medicine, Section of Nephrology

Education History

National Yang-Ming University School of Medicine

Taiwan

PHD :: Institute of Clinical Medicine

National Yang-Ming University School of Medicine

Taiwan

PHD

Publications

Yu-Cheng Tsai, Tsung-Han Hsieh, Yuan-Ru Liao, Ming-Tsun Tsai, Tzu-Ping Lin, Der-Yen Lee, Jihwan Park, Donggun Kim, Katalin Suszták, Shang-Feng Yang, Chih-Ching Lin, Szu-Yuan Li
METTL3-Mediated N6-methyladenosine mRNA Modification and cGAS-STING Pathway Activity in Kidney Fibrosis. Journal of the American Society of Nephrology : JASN (2024)
Ming-Tsun Tsai, Shuo-Ming Ou, Kuo-Hua Lee, Chih-Ching Lin, Szu-Yuan Li
Circulating Activin A, Kidney Fibrosis, and Adverse Events. Clinical journal of the American Society of Nephrology : CJASN (2023)
Chih-Ching Lin, Yu-Te Wu, Wu-Chang Yang, Min-Juei Tsai, Jia-Sin Liu, Chi-Yu Yang, Szu-Yuan Li, Shuo-Ming Ou, Der-Cherng Tarng, Chih-Cheng Hsu
Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade. PloS one 12 (12) (2017)